Turn Neuropathy Into Your Practice's
Highest-Value Cash Program.
20 million Americans live with peripheral neuropathy that medicine manages with a prescription pad. BPA gives your practice the complete system to actually serve them, with marketing, clinical protocols, and automation included from day one.
Americans affected
At-home care model
Avg. cash program value
The Market Traditional
Medicine Can't Reach.
Twenty million patients medicine has given up on.
More than 20 million Americans live with peripheral neuropathy: burning feet, numbness, and stabbing nerve pain that wakes them up at 3 a.m. Most have already cycled through their primary care physician, a neurologist, and a pain management specialist. The answer they get is gabapentin, Lyrica, or Cymbalta: drugs that blunt the sensation without addressing the underlying nerve damage. And because obesity, type 2 diabetes, and chemotherapy are all primary drivers, the patient pool grows every year.
These patients are motivated, and they are cash-pay willing.
When the medications stop working or the side effects become intolerable, these patients start searching for a provider who will actually explain what is happening in their nervous system and offer a structured path toward functional improvement. They are typically middle-aged to retirement-age adults with disposable income or healthcare savings, and they are ready to invest in results. Because the program is cash-pay, there are no claim denials, no prior authorizations, no waiting 90 days to collect 40 cents on the dollar.
One niche that opens the door to many.
The neuropathy demographic overlaps heavily with co-occurring conditions. A neuropathy patient who is also diabetic is frequently a candidate for a metabolic health program. A patient with knee degeneration from altered gait is a knee pain program candidate. Solve neuropathy first, and you earn a multi-program relationship with a patient who has multiple reasons to invest in their health. That is why neuropathy is the starting niche for hundreds of BPA practices.
The Math Is Simple.
Most practices hold their first community seminar within their first month, and first enrollments typically follow soon after. By month three, completed patients start sending referrals that arrive pre-sold. See what members collect →
Four Systems.
One Turnkey Program.
Every practice trying to build this from scratch spends months discovering each requirement through trial and error. Every BPA practice has all four on day one.
Done-For-You Patient Marketing
Paid social and search campaigns, neuropathy-specific landing pages, seminar invitation systems, and follow-up sequences, all built on data from hundreds of practice launches. The marketing runs continuously without your team writing a word of copy.
Clinical Protocols, FDA-Cleared Tech
Treatment protocols built around devices cleared for peripheral neuropathy, nerve regeneration, and pain reduction, designed to be followed by trained staff with physician oversight. You implement proven protocols; you don't invent them.
Hybrid At-Home Model (75%)
Devices ship directly to patients and three-quarters of care happens at home. Your clinic handles assessment and high-value touchpoints. That is how one practice serves significantly more patients without adding treatment rooms. How the hybrid model works →
Patient Education Automation
Automated modules walk every patient through what peripheral neuropathy is, why medication fails it, and what their protocol involves. The education builds compliance, cuts cancellations, and does the belief-building before the consultation ever happens.
What the First 30 Days Look Like.
-
Day 1
Strategy & Market Fit
A strategy session confirms the program fits your market, your clinical setup, and your growth goals, and identifies the constraint that could slow your launch.
-
Week 1
Launch Package Deployed
Marketing assets go live, your team gets clinical training, pricing and program structure are locked, and the automation stack is wired into your practice.
-
Weeks 2-4
First Community Seminar
Your first patient seminar typically lands within the first month, and some practices run it in as little as two weeks. Attendees arrive pre-educated by the marketing system, so the room is full of qualified candidates, not cold leads.
-
Month 1-2
First Enrollments
First patient enrollments typically follow soon after your first seminar. At-home equipment ships, education automation activates, and in-office touchpoints begin.
-
Ongoing
Coaching & Optimization
BPA's coaching team reviews your pipeline, performance, and people. It is the same constraint-based system that runs every BPA practice, so the program compounds instead of plateauing.
This Program Is Not for Everyone.
A strong fit if you…
- Own a chiropractic, PT, or integrated practice and want a cash revenue stream that doesn't depend on insurance
- Are willing to run marketing-driven patient acquisition, including community seminars
- Want protocols your trained staff can deliver, so the program doesn't consume your hours
- See neuropathy as the entry point, with metabolic, knee pain, and other programs layered on later
Not a fit if you…
- Want to keep an insurance-only practice model
- Plan to price the program under $1,500 "to test the waters." Underpricing attracts patients who churn and revenue that can't support the operation
- Intend to deliver every visit in-office. The 75% at-home model is the mechanism that makes the economics work, not a workaround
- Are looking for a course or a binder of ideas rather than an implemented system with ongoing support
What Happens When
You Add This Program.
In their own words: BPA members who launched the neuropathy program in their practices. Browse all member results.
"I wanted to express my gratitude to the Blueprint team as I have been a member for about a year and didn't even launch my first marketing until March of this year. But since then, my practice collections went from averaging about $70k a month to last month where I hit a 23 year career best $181k! Not a bad increase for 8 months!"
"Last month we ramped up our neuropathy marketing. We did our first two seminars, newspaper ads, and facebook marketing. The Result: We not only broke 100K for the first time but ended up just shy of 139K (Almost 2x our previous record)! I used to use my relatively small market as an excuse, but even in a city of 70,000 people there is a huge need for neuropathy treatment."
See The Full Neuropathy Program.
A complete breakdown of the marketing system, clinical model, and automation stack, in under 20 minutes.
Neuropathy Program FAQ.
What is the BPA neuropathy program?
A done-for-you, cash-based peripheral neuropathy program implemented inside your existing practice. It includes the patient marketing system, clinical protocols built on FDA-cleared technologies, automated patient education, and a hybrid care model where roughly 75% of treatment happens at home.
How much revenue can a neuropathy program add to a practice?
Average program value runs $3,000 to $5,000 per patient. At a conservative 10 to 15 new patients per month and a $3,500 average, that is $35,000 to $52,500 in new monthly cash revenue, before cross-enrollment into related programs like metabolic health or knee pain.
How fast can my practice launch the program?
Most practices are up and running within their first month. The launch package, marketing assets, and team training deploy in the opening weeks, and some practices hold their first community seminar in as little as two weeks. First enrollments typically follow soon after the first seminar.
Does this work in smaller markets?
Yes. More than 20 million Americans live with peripheral neuropathy, so the patient base exists in virtually every market. Small and mid-size markets often outperform metros because there is less competition. One BPA member collected $139K in a single month in a city of 70,000 people.
Is the program insurance-billed or cash-pay?
Cash-pay. Patients pay a program fee upfront or on a structured payment plan. There are no claims, no denials, no prior authorizations, and no clawbacks. Revenue is predictable and immediate.
How much of the care happens in my office?
About a quarter of it. Roughly 75% of care happens at home through shipped FDA-cleared devices, automated education modules, and structured protocols. In-office visits are reserved for assessment, protocol advancement, and accountability. That is what lets the program scale without adding treatment rooms or clinical hours.
Which neuropathy patients does the program serve?
Patients with peripheral neuropathy from diabetes, chemotherapy, and idiopathic causes. Most have cycled through gabapentin, Lyrica, or Cymbalta without lasting relief. The marketing system selects for motivated, cash-pay-willing patients before they ever reach your consultation room.
More questions? Visit the full BPA FAQ or ask us directly on a call.
Ready to add Neuropathy
to your practice?
Most doctors who see this program wish they'd started six months earlier. The patient demand is already there. The only question is whether your practice captures it.
Book Your Free Discovery Call →Many practices pair neuropathy with a Knee Pain program or a Metabolic Health program, since these conditions frequently occur together in the same patient. Or explore all 16 niche programs.